News Bulletin
Tuesday, September 30th, 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
Wednesday, September 30, 2026 |
||||
|
8:15 |
ADP Nonfarm Employment Change (Sep) |
90K |
73K |
36K |
|
8:30 |
Core PCE Price Index (YoY)
(Aug) |
3.00% |
3.30% |
3.00% |
|
8:30 |
Core PCE Price Index (MoM)
(Aug) |
0.20% |
0.30% |
0.10% |
|
8:30 |
GDP (QoQ) (Q2) |
2.20% |
1.50% |
2.10% |
|
8:30 |
PCE Price index (YoY)
(Aug) |
3.40% |
3.70% |
3.40% |
|
8:30 |
PCE price index (MoM)
(Aug) |
0.30% |
0.40% |
0.10% |
|
8:30 |
Personal Spending (MoM)
(Aug) |
0.90% |
0.80% |
0.10% |
|
8:30 |
Core PCE Prices (Q2) |
3.30% |
3.60% |
4.40% |
|
8:30 |
GDP Price Index (QoQ)
(Q2) |
6.10% |
6.40% |
3.60% |
|
8:30 |
Retail Inventories Ex Auto (Aug) |
0.10% |
|
0.80% |
|
8:30 |
Goods Trade Balance (Aug) |
-132.60B |
-116.30B |
-118.80B |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
50,906.05 |
52,750.49 |
50,249.34 |
|
NASDAQ |
26,861.06 |
26,244.85 |
24,691.30 |
|
S&P 500 |
7,651.54 |
7,648.73 |
7,216.05 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
NAME |
COMPANY |
Mkt CAP |
EPS/Forcast |
Rev/Forcast |
Time |
|
FEAM |
5E
Advanced Materials, Inc. |
$127.02M |
-$0.221 /
-$0.25 |
$0.000 /
$0.00 |
|
|
MU |
Micron |
$1.20T |
- / $31.73 |
- / $51.33B |
|
|
FDS |
Factset Research |
$9.25B |
$4.520 /
$4.35 |
$634.698M /
$629.83M |
BMO |
|
CALM |
Cal-Maine
Foods |
$3.22B |
-$1.260 /
-$0.77 |
$539.607M /
$561.57M |
BMO |
|
JBL |
Jabil |
$33.41B |
$4.400 /
$4.07 |
$10.616B /
$9.71B |
BMO |
|
CAG |
Conagra Brands |
$6.76B |
$0.410 /
$0.28 |
$2.596B /
$2.59B |
BMO |
|
BSET |
Bassett
Furniture |
$156.28M |
- / $0.13 |
- / $82.77M |
AMC |
|
PRGS |
Progress
Software |
$1.62B |
- / $1.51 |
- / $247.33M |
AMC |
Market
News:
Micron
(NASDAQ: MU) reported fourth quarter EPS of $33.42, $2.26 better
than the analyst estimate of $31.16. Revenue for the quarter came in at $54.23B
versus the consensus estimate of $50.45B.
Constellation
(Nasdaq: CEG) and Amazon (Nasdaq:
AMZN) have announced a 20-year power purchase agreement
covering 690 megawatts of nuclear capacity at the Calvert Cliffs Clean Energy Center in Lusby, Maryland, including approximately 190
megawatts of new generating capacity expected to come online between 2030 and
2032.
Alphabet
Inc. (NASDAQ:GOOGL) shares declined Wednesday heading to
the market close, paring gains to up 0.5% from up over 2%, following a
Bloomberg report that highlighted internal employee skepticism
about the performance of the company’s upcoming Gemini 4 artificial
intelligence model.
Warner Bros
Discovery Inc (WBD) stock has reached a new 52-week high,
hitting $30.93. This milestone reflects a significant upward trend for the
company, with the stock experiencing a 59.38% increase over the past year.
Jefferies identified three biotechnology stocks that appear undervalued
with strong commercial prospects despite a challenging macro environment. All
three of the highlighted stocks are positioned to launch products with
significant peak sales potential.
Delphia Therapeutics (DFTX)
The company's single-dose oral psychedelic DT120 has produced three
positive Phase III datasets in major depressive disorder and generalized
anxiety disorder, each addressing over 20 million U.S. patients. A pre-NDA
meeting in Q4 2026 should support an NDA submission in H1 2027 for GAD. The
company could potentially file jointly for both indications, given DT120's two
breakthrough therapy designations.
Axsome Therapeutics (AXSM)
Auvelity is approved
for both MDD and Alzheimer's agitation, with the latter indication launched in
June 2026. Weekly total prescriptions and new prescriptions are reaching record
highs, suggesting sample conversion is occurring.
BridgeBio Pharma (BBIO)
The company is positioned to launch four blockbuster oral medications. Attruby in ATTR-CM could reach $3-4 billion in U.S. peak
sales. Sales are expected to grow $25-30 million quarter-over-quarter from the
Q2 2026 base of $222 million, before accelerating in late 2027.
For
internal use only